Next Article in Journal
Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
Next Article in Special Issue
P4 ATPases: Flippases in Health and Disease
Previous Article in Journal
A Molecular Dynamics Study of the Structural and Dynamical Properties of Putative Arsenic Substituted Lipid Bilayers
Previous Article in Special Issue
Structure and Conformational Dynamics of DMPC/Dicationic Surfactant and DMPC/Dicationic Surfactant/DNA Systems
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2013, 14(4), 7716-7741; doi:10.3390/ijms14047716

Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function

1
Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza, Zaragoza E-50013, Spain
2
CIBER de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Madrid E-28029, Spain
3
Departamento de Farmacología y Fisiología, Facultad de Ciencias de la Salud y del Deporte, Universidad de Zaragoza, Huesca E-22002, Spain
*
Author to whom correspondence should be addressed.
Received: 19 February 2013 / Revised: 20 March 2013 / Accepted: 29 March 2013 / Published: 9 April 2013
(This article belongs to the Special Issue Phospholipids: Molecular Sciences 2012)
View Full-Text   |   Download PDF [801 KB, uploaded 19 June 2014]   |  

Abstract

High-density lipoprotein (HDL) levels are an inverse risk factor for cardiovascular diseases, and sphingomyelin (SM) is the second most abundant phospholipid component and the major sphingolipid in HDL. Considering the marked presence of SM, the present review has focused on the current knowledge about this phospholipid by addressing its variable distribution among HDL lipoparticles, how they acquire this phospholipid, and the important role that SM plays in regulating their fluidity and cholesterol efflux from different cells. In addition, plasma enzymes involved in HDL metabolism such as lecithin–cholesterol acyltransferase or phospholipid transfer protein are inhibited by HDL SM content. Likewise, HDL SM levels are influenced by dietary maneuvers (source of protein or fat), drugs (statins or diuretics) and modified in diseases such as diabetes, renal failure or Niemann–Pick disease. Furthermore, increased levels of HDL SM have been shown to be an inverse risk factor for coronary heart disease. The complexity of SM species, described using new lipidomic methodologies, and their distribution in different HDL particles under many experimental conditions are promising avenues for further research in the future. View Full-Text
Keywords: high-density lipoproteins; phospholipids; sphingomyelin high-density lipoproteins; phospholipids; sphingomyelin
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Martínez-Beamonte, R.; Lou-Bonafonte, J.M.; Martínez-Gracia, M.V.; Osada, J. Sphingomyelin in High-Density Lipoproteins: Structural Role and Biological Function. Int. J. Mol. Sci. 2013, 14, 7716-7741.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top